Syneron Medical Ltd (ELOS) Reports In-Line Q3 EPS

Syneron Medical Ltd (NASDAQ: ELOS) reported Q3 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $60.3 million versus the consensus estimate of $58.32 million.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c